Liquidia Corp. planned insider sales
In the twelve months since 11 October 2025 insiders at Liquidia Corp. filed 36 Form 144 notices of planned sales, 2.6 million shares worth $136.4 million at the time of filing, from 14 sellers. The latest, filed 14 September 2026: Ramandeep Singh (director), 8,468 shares worth $560,243, planned for around 14 September 2026 through Morgan Stanley Smith Barney LLC Executive Financial Services.
| Filed | Seller | Relationship | Shares | Value | Planned sale | Broker | How acquired | Filing |
|---|---|---|---|---|---|---|---|---|
| 14 September 2026 | Ramandeep Singh | Director | 8,468 | $560,243 | 14 September 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Stock Option Exercise | Form 144 |
| 11 September 2026 | Ramandeep Singh | Director | 9,024 | $619,210 | 11 September 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Stock Option Exercise | Form 144 |
| 21 August 2026 | Jason Adair | Officer | 73,631 | $5.2 million | 21 August 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Exercise of Stock Options; Restricted Stock Units | Form 144 |
| 19 August 2026 | Rajeev Saggar | Officer | 50,000 | $3.7 million | 19 August 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Stock Option Exercise | Form 144 |
| 19 August 2026 | Katherine T. Rielly-Gauvin | Director | 55,182 | $4.1 million | 19 August 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Exercise of Stock Options | Form 144 |
| 17 August 2026 | Rajeev Saggar | Officer | 29,534 | $2.3 million | 17 August 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Performance Shares; Restricted Stock | Form 144 |
| 11 June 2026 | Sarah Krepp | Officer | 24,880 | $1.6 million | 11 June 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Employee Stock Purchase Plan; Restricted Stock Units | Form 144 |
| 10 June 2026 | Canaan VIII LP | Director | 200,000 | $13.0 million | 10 June 2026 | UBS Financial Services Inc | pre-IPO investment | Form 144 |
| 8 June 2026 | Canaan VIII LP | Director | 200,000 | $12.8 million | 8 June 2026 | UBS Financial Services Inc | pre-IPO investment | Form 144 |
| 4 June 2026 | Paul B Manning | Director | 200,000 | $11.1 million | 4 June 2026 | Fidelity Brokerage Services LLC | Private Investment in Public Equity; Registered Direct Offering | Form 144 |
| 4 June 2026 | Canaan VIII LP | Director | 200,000 | $13.0 million | 4 June 2026 | UBS Financial Services Inc | Pre-IPO Investment | Form 144 |
| 1 June 2026 | Kirsch Arthur S | Director | 30,000 | $1.8 million | 1 June 2026 | Fidelity Brokerage Services LLC | Market Purchase | Form 144 |
| 21 May 2026 | Ramandeep Singh | Director | 29,494 | $1.8 million | 21 May 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Stock Option Exercise | Form 144 |
| 20 May 2026 | Serendipity Biopharma Llc | Director, Officer | 106,428 | $6.4 million | 20 May 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Merger or Acquisition | Form 144 |
| 14 May 2026 | Serendipity Biopharma Llc | Director, Officer | 100,000 | $5.8 million | 14 May 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Merger or Acquisition | Form 144 |
| 11 May 2026 | Canaan VIII LP | Director | 318,893 | $15.9 million | 11 May 2026 | UBS Financial Services Inc | pre-IPO investment | Form 144 |
| 8 May 2026 | Serendipity Biopharma Llc | Director, Officer | 100,000 | $4.2 million | 8 May 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Merger or Acquisition | Form 144 |
| 7 May 2026 | Serendipity Biopharma Llc | Director, Officer | 25,000 | $1.1 million | 7 May 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Merger or Acquisition | Form 144 |
| 17 April 2026 | Serendipity Biopharma Llc | Director, Officer | 68,839 | $2.8 million | 17 April 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Merger or Acquisition | Form 144 |
| 16 April 2026 | Serendipity Biopharma Llc | Director, Officer | 25,000 | $1.0 million | 16 April 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Merger or Acquisition | Form 144 |
| 15 April 2026 | Serendipity Biopharma Llc | Director, Officer | 24,733 | $957,414 | 15 April 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Merger or Acquisition | Form 144 |
| 15 April 2026 | Michael Kaseta | Officer | 139,390 | $5.4 million | 15 April 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Employee Stock Purchase Plan; Exercise of Stock Options; Restricted Stock Units | Form 144 |
| 14 April 2026 | Michael Kaseta | Officer | 3,000 | $116,550 | 14 April 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Exercise of Stock Options | Form 144 |
| 10 April 2026 | Michael Kaseta | Officer | 23,821 | $960,463 | 10 April 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Exercise of Stock Options | Form 144 |
| 10 April 2026 | Serendipity Biopharma Llc | Director, Officer | 25,000 | $1.0 million | 10 April 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Merger or Acquisition | Form 144 |
| 9 April 2026 | Serendipity Biopharma Llc | Director, Officer | 25,000 | $954,750 | 9 April 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Merger or Acquisition | Form 144 |
| 9 April 2026 | Michael Kaseta | Officer | 133,789 | $5.1 million | 9 April 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Exercise of Stock Options | Form 144 |
| 27 March 2026 | Canaan VIII LP | Board Member | 62,550 | $2.1 million | 27 March 2026 | UBS Financial Services Inc | Issuer | Form 144 |
| 26 March 2026 | Canaan VIII LP | Board Member | 7,684 | $285,000 | 26 March 2026 | UBS Financial Services Inc | Pre-IPO Investment | Form 144 |
| 13 March 2026 | Sarah T Krepp | Officer | 16,261 | $617,918 | 13 March 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Performance Shares; Restricted Stock | Form 144 |
| 13 March 2026 | Rajeev Saggar | Officer | 35,365 | $1.3 million | 13 March 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Restricted Stock | Form 144 |
| 13 March 2026 | Ramandeep Singh | Director | 40,359 | $1.5 million | 13 March 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Restricted Stock; Stock Option Exercise | Form 144 |
| 9 March 2026 | Scott Moomaw | Officer | 100,000 | $3.6 million | 9 March 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Employee Stock Purchase Plan; Exercise of Stock Options; Restricted Stock Units | Form 144 |
| 18 November 2025 | Jason Adair | Officer | 35,656 | $1.0 million | 18 November 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | Exercise of Stock Options | Form 144 |
| 7 November 2025 | Dana Boyle | Officer | 29,004 | $727,581 | 7 November 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | Employee Stock Purchase Plan; Restricted Stock | Form 144 |
| 5 November 2025 | Rajeev Saggar | Officer | 71,381 | $1.9 million | 5 November 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | Employee Stock Purchase Plan; Restricted Stock | Form 144 |
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read more
Value is the filer's own aggregate market value. Whether the sale happened shows up later on Form 4, on the insiders page.Source
Form 144 filings on EDGAR for Liquidia Corp.: the company's filing index, each notice read from its own XML.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.